foxo4-dri p53 Research Peptide – 15mg FOXO4-DRI

Timing and Frequency Considerations: AOD-9604 is most commonly administered once daily in the morning on an empty stomach to maximize absorption and align with natural circadian metabolic rhythms

Many of our clients enhance their recovery by pairing peptide therapy with our signature IV Vitamin therapy to ensure their body has the necessary hydration and micronutrients to support the healing process

Perhaps most significant for neuropathy patients was the finding on autotomy behavior

Healthcare providers should think about each patients needs and what they prefer

The 83-amino-acid LR3 peptide is more resistant to certain forms of degradation than native IGF-1 but still requires careful protocol attention